As of 2026-03-15, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 19.0x | 17.3x |
| Forward P/E multiples | 21.8x - 22.7x | 22.2x |
| Fair Price | (5.98) - (5.21) | (5.40) |
| Upside | -1818.4% - -1597.0% | -1652.7% |
| Date | EV/EBITDA |